SnagRx vs BreezeMeds: Pricing, meds, and policy differences
Quick verdict: SnagRx is the lower-cost, price-locked compounded option on an annual plan; BreezeMeds lists higher starting prices and offers both injectable and oral GLP-1 formats but requires confirmation of product type and terms. This article compares SnagRx vs BreezeMeds across the clearest differences so you can decide which fit your priorities.
See SnagRx pricing and enrollment
Key differences to compare
This SnagRx vs BreezeMeds comparison focuses on five distinctive differences evident from the source: pricing and plan commitment, compounded versus injectable/oral product presentation, transparency about pharmacies and clinicians, approval and shipping timelines, and guarantees or unclear billing details.
Pricing and plan commitment
SnagRx: Compounded semaglutide is offered from $69/month on a 12-month plan (month-to-month is $99). The $69 and $119 tirzepatide figures are explicitly tied to the 12-month plan; the company states the annual plan locks that rate for the life of treatment.
BreezeMeds: Lists semaglutide injection starting at $199/month and tirzepatide injection starting at $299; oral formulations are displayed from $399. A separate $169 figure appears on the site without a clear product association. BreezeMeds therefore shows higher starting prices and less clear linkage between specific prices and specific products.
Compounded versus product formats
SnagRx: Offers compounded semaglutide and compounded tirzepatide. The source repeatedly notes these are compounded medications and includes the regulatory qualification that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
BreezeMeds: Promotes injectable and oral GLP-1 options, including oral semaglutide and oral tirzepatide displayed from $399. The source notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Transparency about pharmacies and clinicians
SnagRx: Names its four US 503A partner pharmacies and identifies its clinician network as OpenLoop Health. SnagRx states OpenLoop Health clinicians typically review intake within five hours and that prescriptions are filled by named US 503A compounding pharmacies.
BreezeMeds: The source lists online intake and personalized treatment plans but does not name partner pharmacies or clinician partners in the captured evidence. BreezeMeds advises treatment is available only when a licensed clinician determines it is medically appropriate.
Approval, shipping, and logistics
SnagRx: States intake takes about five minutes, clinician review typically within five hours and always within 24, with approved orders shipping next-day via UPS or FedEx in temperature-controlled packaging. SnagRx states next-day delivery in 1-2 days and free shipping on its site copy.
BreezeMeds: Promotes discreet home delivery but the captured evidence does not include specific timelines, named carriers, or guaranteed review windows. Shipping and state-service details should be confirmed with BreezeMeds.
View BreezeMeds options and eligibility
Side-by-side at-a-glance
| Criteria | SnagRx | BreezeMeds |
|---|---|---|
| Starting price (semaglutide) | $69/mo on 12-month plan; $99/mo month-to-month | Starting at $199/mo (injection); other figures shown from $169 and $399 |
| Product format | Compounded semaglutide and tirzepatide | Injectable and oral semaglutide and tirzepatide displayed |
| Pharmacy and clinician transparency | Names four US 503A pharmacies and OpenLoop Health clinician network | Online intake and personalized plans; partner names not captured |
| Approval and shipping | Intake ~5 minutes; clinician review typically within 5 hours; next-day shipping in temperature-controlled packaging | Discreet home delivery promoted; specific timelines not captured |
| Regulatory note | Compounded medications not FDA-approved; stated on site | Approval status must be confirmed; branded and compounded products not interchangeable |
Guarantees, billing, and unclear terms
SnagRx: States a full refund if a prescription is declined and mentions a 6-month weight-loss guarantee with terms. It also emphasizes no membership fee and cancel anytime on its captured copy. The $69/$119 rates are conditional on the 12-month plan.
BreezeMeds: The source notes affordable pricing and discreet shipping but captured evidence shows fees, billing commitments, and renewal terms were not fully visible and the $169 figure is not clearly tied to a specific product. Consumers should confirm fee structure, renewal terms, and state availability before enrolling.
Check SnagRx enrollment and refund policy
Which to choose
SnagRx vs BreezeMeds summary: SnagRx suits cost-driven patients who prioritize predictable, locked pricing across a full titration and named pharmacy and clinician partners, provided they accept compounded medications and the 12-month plan requirement for the lowest rates. BreezeMeds may suit people who want the option of injectable and oral GLP-1 formats but who should confirm exact product types, pricing, renewal terms, and state availability before enrolling.
Confirm BreezeMeds pricing and eligibility
Choose SnagRx if you want locked, bottom-of-market compounded pricing on a 12-month plan and named US 503A pharmacies with a stated clinician review window. Choose BreezeMeds if you need injectable or oral GLP-1 formats and will verify the specific product, pricing, and terms before enrolling. This direct SnagRx vs BreezeMeds comparison uses only the supplied source facts; verify current offers with each provider.